Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

COSCIENS Biopharma Inc

CSCI.TO ✓ COMPLIANT ☆ Track — members

TSX · Healthcare · Biotechnology & Medical Research ·

Canada Micro Cap Analyst: N/A

Last Close

$5.68

▲ +0.25%

Market Cap $6.00M · Vol 786

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$6.00M

Micro Cap

Div Yield

N/A

Dividend with no set frequency

EPS Growth

N/A

YoY

RSI (14)

54.79

Momentum

Beta

1.93

vs Market

52W High

$10.67

45.61% below

52W Low

$2.38

136.48% above

Volume

786

Avg 1.02K

P/B

1.71

Price-to-book

ROE

N/A

Return on equity

Free Float

72.47%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, COSCIENS Biopharma Inc (CSCI.TO) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CSCI.TO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+11.77%

-7.18%

+5.91%

-4.14%

YTD

-7.51%

-43.27%

-83.40%

-96.95%

Financials & Valuation

TTM · Annual

Total Revenue	$7.50M
Net Income	$-10,358,000.00
Revenue Growth (YoY)	+36.12%
Gross Margin	35.30%
Operating Margin	-138.24%
Net Profit Margin	-138.14%
ROE	N/A
ROA · ROIC	-36.63% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.87
P/B	1.71
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	1.06M

Technical Indicators

50-Day SMA	$6.17
200-Day SMA	$5.89
RSI (14)	54.79
Beta	1.93
52-Week High	$10.67
52-Week Low	$2.38

Volume Today	786
Avg Daily Volume (30D)	1.02K
Relative Volume	0.77x
Volatility (10D)	28.98
Volatility (30D)	135.11
Free Float	72.47%

Analyst Consensus

N/A

Current Price $5.68

Mean Target N/A

52W Low$2.38 52W High$10.67

Current

Target

$2.38 $10.67

Current Analyst target

· 0 analysts

Identifiers

ExchangeTSX

FIGIBBG001S63T33

ISINCA22112H1010

CountryCanada

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

COSCIENS Biopharma Inc. is a Canada-based life science company. The Company is developing and commercializing a diversified portfolio of products for the cosmeceutical, nutraceutical and pharmaceutical markets. The Company’s patented technologies include the Pressurized Gas eXpanded (PGX) technology, which is a technology that generates high-value yields of active ingredients from natural-based resources for use in novel cosmeceutical, nutraceutical and pharmaceutical products. The Company's two products, oat beta glucan and avenanthramides, are found in household-name cosmetic and personal care brands. These products are manufactured from the Company’s proprietary oat extraction manufacturing technology and are known for their well-documented health benefits. Its lead product, macimorelin (Macrilen; Ghryvelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD).